Phathom Pharmaceuticals, Inc.PHATNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank14
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-166.78M
↓ 37% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-121.67M
Historical baseline
PeriodValueYoY Change
2025$-166.78M+37.5%
2024$-266.77M-93.9%
2023$-137.58M+6.1%
2022$-146.53M+1.3%
2021$-148.46M-113.0%
2020$-69.69M-90.9%
2019$-36.51M-3468.9%
2018$-1.02M-